Advisers to the US Food and Drug Administration voted 13-10 Tuesday to recommend emergency use authorization of a pill made by Merck and Ridgeback Biotherapeutics to help treat Covid-19.
Members of the FDA's Antimicrobial Drugs Advisory Committee were split in their vote to recommend molnupiravir, which can reduce the relative risk someone will progress to severe disease or death by about 30%.
The absolute reduction in risk of severe disease or death was 3% -- 9.7% of people who took placebo died, compared to 6.8% of those given molnupiravir.
If authorization is granted, the drug would be the first oral antiviral treatment to fight Covid-19. It comes in capsule form.
It is a one important step in treatment of this elusive disease. Just a thought.
No comments:
Post a Comment